Related references
Note: Only part of the references are listed.Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
Hitt J. Sharma et al.
EXPERT REVIEW OF VACCINES (2023)
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin
Vishal Rathod et al.
FRONTIERS IN IMMUNOLOGY (2023)
Tdap Booster Vaccination for Adults: Real-World Adherence to Current Recommendations in Italy and Evaluation of Two Alternative Strategies
Maurizio Lecce et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
Asmik Asatryan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults
Hitt Sharma et al.
VACCINE (2021)
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
Fiona P. Havers et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Pertussis vaccines and protective immunity
Parul Kapil et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens
Gowrisankar Rajam et al.
BIOLOGICALS (2019)
Safety and Immunogenicity of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administered to Children 10 or 11 Years of Age
Gary S. Marshall et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology
Sarah L. Sheridan et al.
EXPERT REVIEW OF VACCINES (2014)
Duration of Protection After First Dose of Acellular Pertussis Vaccine in Infants
Helen E. Quinn et al.
PEDIATRICS (2014)
Pertussis vaccines: Position paper of Indian Academy of Pediatrics (IAP)
Vipin M. Vashishtha et al.
INDIAN PEDIATRICS (2013)
Pertussis in Older Adults: Prospective Study of Risk Factors and Morbidity
Bette C. Liu et al.
CLINICAL INFECTIOUS DISEASES (2012)
Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): Results of two randomized trials
Wayde M. Weston et al.
VACCINE (2012)
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials
Pierre Van Damme et al.
VACCINE (2011)
Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™)
Fengcai Zhu et al.
HUMAN VACCINES (2010)
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age
Mark Blatter et al.
VACCINE (2009)
Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus
Pieter G. M. van Gageldonk et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: Safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules
Michael E. Pichichero et al.
CLINICAL PEDIATRICS (2006)
Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents
ME Pichichero et al.
PEDIATRICS (2006)
Efficacy of an acellular pertussis vaccine among adolescents and adults
JI Ward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults
ME Pichichero et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis
J Storsaeter et al.
VACCINE (2003)
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis
J Taranger et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
